These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 31521416)
21. Introducing Personalized Medicine Into Pediatric Homozygous Familial Hypercholesterolemia Care. Gidding SS; Hegele RA Arterioscler Thromb Vasc Biol; 2022 Dec; 42(12):1458-1460. PubMed ID: 36325896 [No Abstract] [Full Text] [Related]
22. Homozygous familial hypercholesterolemia in childhood: Genotype-phenotype description, established therapies and perspectives. Sanna C; Stéphenne X; Revencu N; Smets F; Sassolas A; Di Filippo M; Descamps OS; Sokal EM Atherosclerosis; 2016 Apr; 247():97-104. PubMed ID: 26894473 [TBL] [Abstract][Full Text] [Related]
23. Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia. Makino H; Harada-Shiba M Ther Apher Dial; 2003 Aug; 7(4):397-401. PubMed ID: 12887721 [TBL] [Abstract][Full Text] [Related]
24. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene. Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584 [TBL] [Abstract][Full Text] [Related]
25. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia. Græsdal A; Bogsrud MP; Holven KB; Nenseter MS; Narverud I; Langslet G; Brekke M; Retterstøl K; Arnesen KE; Ose L J Clin Lipidol; 2012; 6(4):331-9. PubMed ID: 22836070 [TBL] [Abstract][Full Text] [Related]
33. [Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment]. Češka R; Štulc T; Votavová L; Schwarzová L; Vaclová M; Freiberger T Vnitr Lek; 2016; 62(11):887-894. PubMed ID: 28128575 [TBL] [Abstract][Full Text] [Related]
34. Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years. Palcoux JB; Atassi-Dumont M; Lefevre P; Hequet O; Schlienger JL; Brignon P; Roussel B Ther Apher Dial; 2008 Jun; 12(3):195-201. PubMed ID: 18503695 [TBL] [Abstract][Full Text] [Related]
35. Early development of xanthoma and coronary disease in a young female with homozygous familial hypercholesterolemia. Zhao X; Bu L; Qin S; Kong D; Fan B; Ge J Int J Cardiol; 2014 Sep; 176(1):e15-9. PubMed ID: 25043216 [No Abstract] [Full Text] [Related]
37. [LDL oxidation in homozygous familial hypercholesterolemia: effects of selective LDL-apheresis treatment]. Napoli C; Postiglione A; Scarpato N; Corso G; Ambrosio G; Condorelli M; Mancini M; Chiariello M Cardiologia; 1996 May; 41(5):435-9. PubMed ID: 8767632 [TBL] [Abstract][Full Text] [Related]
38. Delayed diagnosis of familial hypercholesterolemia: a case report of two patients from Egypt. Alkhateeb AA; Kassem HH; Wahba WA; Algowhary MI J Clin Lipidol; 2013; 7(6):683-8. PubMed ID: 24314368 [TBL] [Abstract][Full Text] [Related]
39. Familial hypercholesterolemia in children and adolescents: A clinical perspective. de Ferranti SD J Clin Lipidol; 2015; 9(5 Suppl):S11-9. PubMed ID: 26343208 [TBL] [Abstract][Full Text] [Related]
40. Lipoprotein-apheresis in familial hypercholesterolemia: Long-term patient compliance in a French cohort. Beliard S; Gallo A; Duchêne E; Carrié A; Bittar R; Chapman MJ; Bruckert E; Saheb S Atherosclerosis; 2018 Oct; 277():66-71. PubMed ID: 30176566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]